Shuttle Pharmaceuticals Holdings, Inc.
SHPH· Nasdaq
Released Nov 13, 2024, after the close
10-Q filed Nov 13, 2024, 44 days after period end · 0001493152-24-045176
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$3.78M | -$1.79M | -$998.43K | -$216.96K |
| EPS Diluted | -$39.83 | -$0.91 | -$0.10 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Shuttle Pharmaceuticals Holdings, Inc. · CIK 1757499 · Engraved from SEC EDGAR